Independent Portfolio Consultants’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Independent Portfolio Consultants’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-21,695	Closed	-$608K	–	871
2016 Q3	$608K	Sell	21,695 -10	-0%	-$336	0.19%	189
2016 Q2	$760K	Buy	21,705 +7,985	+58%	+$251K	0.24%	128
2016 Q1	$376K	Buy	13,720 +10,760	+364%	+$317K	0.11%	253
2015 Q4	$101K	Buy	2,960 +560	+23%	+$17.5K	0.03%	470
2015 Q3	$69K	Sell	2,400 -800	-25%	-$34.2K	0.02%	537
2015 Q2	$143K	Buy	+3,200	New	+$120K	0.03%	428

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Independent Portfolio Consultants's DPLO Position: Q4 2016 in Review

Independent Portfolio Consultants sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 21,695 shares — an estimated $608K sold.

Independent Portfolio Consultants first reported a position in DPLO in Q2 2015 and held it in 6 quarters. The position peaked at $760K in Q2 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

Independent Portfolio Consultants reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
Independent Portfolio Consultants sold 21,695 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $608K.
Independent Portfolio Consultants first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 6 quarters.
Independent Portfolio Consultants's DIPLOMAT PHARMACY, INC. position peaked at $760K in Q2 2016.
174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on Independent Portfolio Consultants's 13F filing for Q4 2016, filed 12 Jan 2017.